Back to search
FDAFDA · Food and drugs·Recall number D-0316-2020

Equate Maximum Strength Ranitidine Tablets, USP 150 mg Acid Reducer 130 Tablets Distributed by Wal-Mart Stores, Inc. Bentonville, AR 72716 a) Twin Pack NDC: 49035-100-07; b) Single Pack NDC: 49035-100-00

Published November 20, 2019 · Recall initiated: September 24, 2019

Summary

FDA records drug Class II recall D-0316-2020, published November 20, 2019 and initiated September 24, 2019. Recalling firm: Apotex Inc.; Status: Completed; Reported quantity: 1,132,453 bottles; Lot: All lots remaining within expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA).

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Apotex Inc.
Distributor
Nationwide
Lot
All lots remaining within expiry.
Risk classification
Class II
Area (FDA)
drug
Country
Canada

Related recalls

Questions about this recall

Was Equate Maximum Strength Ranitidine Tablets, USP 150 mg Acid Reducer 130 Tablets Distributed by Wal-Mart Stores, Inc. Bentonville, AR 72716 a) Twin Pack NDC: 49035-100-07; b) Single Pack NDC: 49035-100-00 recalled?

Yes. FDA published recall D-0316-2020 on November 20, 2019. Reported hazard: GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA).

What should I do if I have this product?

Voluntary: Firm initiated · Press Release